Solventum's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Solventum's ROI in the third quarter of 2026?
Solventum Corporation achieved a return on average invested assets (ROI) of 1.36 % in its third quarter of 2026, which is below Solventum's average return on investment, which stands at 8.13%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 87 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2026 from 713 to 729.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Investment Change TTM	-11.28 %	-6.26 %	5.23 %	9.35 %	8.41 %
Y / Y Net Income Change TTM	-89.76 %	277.37 %	393.79 %	916.99 %	1149.18 %
Investment (TTM) in Millions	10,590	10,580	12,136	12,731	12,435
Return On Investment (TTM)	1.36 %	11.98 %	11.19 %	11.89 %	11.75 %
SOLV's Overall Ranking	# 729	# 713	# 0	# 0	#
Seq. Investment Change TTM	-3.85 %	-6.49 %	-2.17 %	0.87 %	1.59 %
Seq. Net Income Change TTM	-89.12 %	0.14 %	-7.97 %	2.1 %	301.05 %
Net Income (TTM) in Millions	156	1,434	1,432	1,556	1,524

SOLV Company Profile >> Back to SOLV Roi Comparisons >> See Annual SOLV Return On Investment

Return On Investment SOLV's Ranking
Within:	No.
Industry	# 24
Sector	# 88
Overall	# 729

Return On Investment Statistics
High	Average	Low
11.98 %	8.13 %	2.98 %
(Jun 30 2026)		(Jun 30 2025)

Financial Statements
Solventum's III. Quarter Investments	$ 10,590 Millions	SOLV's Balance sheet
Solventum's III. Quarter Income	$ -12 Millions	Quarterly SOLV's Income Statement
SOLV's Income by Division		See SOLV's Income by Division

SOLV Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	10,765	12,280	0	0	0
Y / Y Investment Growth	-12.34 %	-	-	-	-
Net Income in Millions	1,556	479	0	0	0
Y / Y Net Income Growth	224.84 %	-	-	-	-
Annual Return On Investment	14.45 %	3.9 %	-	-	-

Annual Roi Comment

In the fiscal year 2025 ROI improved to 14.45 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SOLV's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SOLV's Competitors
Subscribers only: Roi for Solventum's Suppliers
Subscribers only: Return On Investment for SOLV's Customers

Other Ratios
SOLV's Roa	SOLV's Inventory Turnover Ratio	SOLV's Growth Rates	SOLV's Dividend Statistics
	SOLV's Profitability Ratios	SOLV's Asset Turnover Ratio	SOLV's Dividend Growth
SOLV's Roe	SOLV's Valuation Ratios	SOLV's Financial Strength Ratios	SOLV's Dividend Payout Ratio

Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector	ROI
Lifestance Health Group Inc	3.71 %
U S Physical Therapy Inc	3.33 %
Conmed Corporation	3.16 %
Integer Holdings Corporation	3.13 %
Avantor Inc	3.11 %
Innovage Holding Corp	2.95 %
Ligand Pharmaceuticals Incorporated	2.84 %
Revvity Inc	2.35 %
Pfizer Inc	2.34 %
Jazz Pharmaceuticals Plc	2.12 %
Teva Pharmaceutical Industries Limited	1.96 %
Icu Medical Inc	1.74 %
Biogen Inc	1.26 %
Community Health Systems Inc	1.03 %
Waters Corporation	0.51 %
Integra Lifesciences Holdings Corp	0.31 %

Date modified: 2026-11-08T13:46:17+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.